Search results for "Diabetes"
Diabetes education programs show mixed results
Educational programs for patients with uncontrolled diabetes showed some success but overall had mixed results in three recent trials.
https://immattersacp.org/weekly/archives/2011/10/18/4.htm
18 Oct 2011
MKSAP Quiz: routine follow-up visit for diabetes and hyperlipidemia
A 59-year-old woman is evaluated during a routine follow-up visit. She was recently diagnosed with type 2 diabetes mellitus and hyperlipidemia. She feels well. Medications are metformin, atorvastatin, and aspirin. Following a physical exam and lab results, what is the most appropriate diagnostic test to perform next?
https://immattersacp.org/weekly/archives/2014/03/11/3.htm
11 Mar 2014
Updated warnings on fluoroquinolones, new diabetes drug
This column reviews a warning on fluoroquinolones with a risk of disabling and potentially permanent side effects, as well as approval of an injection to improve glycemic control in adults with type 2 diabetes.
https://immattersacp.org/archives/2016/10/fda.htm
1 Oct 2016
Early Bird rates extended for ACP's Internal Medicine Meeting 2022
The new registration deadline to receive the discounted rate is Feb. 28.
https://immattersacp.org/weekly/archives/2022/02/08/5.htm
8 Feb 2022
Intensive blood pressure targets didn't reduce mortality in type 2 diabetes
Intensive hypertension treatment slightly reduced the risk of stroke in type 2 diabetics, but had no effect on mortality or myocardial infarction, a new review found.
https://immattersacp.org/weekly/archives/2012/08/14/6.htm
14 Aug 2012
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, I.M. Matters Weekly from ACP.
https://immattersacp.org/archives/2024/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2024
Large review compares benefits, harms of drugs to treat type 2 diabetes
High-certainty evidence indicated that sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists reduce all-cause death, while finerenone probably also reduced mortality based on moderate-certainty evidence.
https://immattersacp.org/weekly/archives/2023/04/18/4.htm
18 Apr 2023
Potential problematic prescribing in older women
Prescription of systemic estrogen therapy after menopause could be a red flag for use of other medications linked to dementia.
https://immattersacp.org/archives/2024/04/potential-problematic-prescribing-in-older-women.htm
1 Apr 2024
Tailoring diabetes screening by race, ethnicity may lead to earlier diagnosis
Researchers used data from the National Health and Nutrition Examination Survey to determine the body mass index and age thresholds for diabetes screening in major racial/ethnic minority populations.
https://immattersacp.org/weekly/archives/2022/05/10/1.htm
10 May 2022
Tirzepatide for weight management, at-home STI tests
This column reviews recent recalls, alerts, and approvals.
https://immattersacp.org/archives/2024/01/tirzepatide-for-weight-management-at-home-sti-tests.htm
1 Jan 2024